New device aims to close wide gum clefts without bone grafts
NCT ID NCT07306429
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a special device placed inside the mouth to slowly pull bone across a wide gap in the gum (alveolar cleft) in 8 patients aged 7 to 20. The goal was to close the gap without needing a bone graft. Researchers measured changes in the cleft size, tooth movement, and bone health after treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Bone-borne intraoral distractor (device)
- What this could lead to
- If successful, this device could offer a new way to close wide alveolar clefts without repeated bone grafts, potentially improving outcomes for patients.
- What could go wrong
- This was a very small study (8 participants) with no control group, so results may not apply broadly. The procedure carries risks like infection or device failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
8 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Dec 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
7 to 20 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with wide alveolar clefts more than 8ml either unilateral or bilateral or median facial cleft. * Patients who had previous failed grafting also may be included. * Age range of patients 7-20 years old, with no gender prediction, able to read and sign the informed consent (parents) * Patients with median facial clefts. Exclusion Criteria: * Narrow alveolar cleft * Syndromic patients. * Oral soft tissues defects, inflammation, infections and bone metabolism disturbance. * Allergy to titanium implant. * Patient with systemic disease and immunocompromised patient.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alveolar cleft are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of oral and dental medicine for Girls AlAzhar University
Cairo, Cairo Governorate, 12345, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Baby teeth stem cells may spare kids a second surgery for cleft palate repair
- Jaw vs. hip bone: which graft works best for cleft repair?
- New device shrinks jaw gaps in cleft patients, boosts graft success
- New dissolvable foods could ease Post-Surgery feeding for kids
- Could a diabetes drug strengthen bone repair in kids with cleft palate?
- Cheek flap may boost bone growth in cleft repair